RecruitingPhase 1Drug trialLopinavir/Ritonavir in PLWH With High-Grade AINThis study is being done to assess the safety of lopinavir/ritonavir in patients with PLWH with AIN. 30 participants will be recruited and can expect to be on active study for approximately 3 months and long term follow up for 40 weeks.